Pharmacovigilance National Contact Person Provision

Abstract blue image with turquoise hexagon and molecular pattern

UK National Contact Person for Pharmacovigilance – NCP

Let’s work together to ensure the safety and success of your products with expert pharmacovigilance support.

All EU Marketing Authorisation Holders with a QPPV located in the EU and hold UK Marketing authorisations will now require to have a National Contact Person for Pharmacovigilance (NCP) who is living in the UK and will report to the QPPV of the MAH in the EU.

The NCP will have the responsibility on the MAH’s behalf to be their main contact person with the MHRA and report back to the MAH.

The MAH is required to register the name and contact details of the NCP with the MHRA, once they have been appointed. The MAH should notify the MHRA of these details via their submissions portal.

PDS clients benefit from a personal service from our highly qualified, forward thinking, proactive and collaborative Pharmacovigilance team, who will work with you across all aspects of your project.    

Adopting a partnership approach, our team will work with you as much as for you, to deliver positive outcomes for your business on every project we undertake.

“PDS came on board to help during the setup of a new project with the original contract being for 3 years. 9 years later and PDS are still adding value to our business and are a trusted contractor.  PDS deliver all that they say they will and more, always on time and on budget. The team at PDS bring a different perspective to the project and business and have become a valued member of our project team.”

Head of PV Compliance – Top 5 Pharma Company

Email us now to discuss your project with one of our Team

Together, we’ll safeguard patient health and maintain compliance with confidence.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PDS rings blue svg